Robert Kramer
Chief Tech/Sci/R&D Officer bij PORTAGE BIOTECH INC.
Vermogen: 82 766 $ op 31-03-2024
Profiel
Robert Alan Kramer is the founder of SalvaRx Group Plc, which was founded in 2007.
He is currently a Director at Phusis Therapeutics, Inc. since 2014, a Director at iOX Therapeutics Ltd.
since 2022, and the Chief Scientific Officer at Portage Biotech, Inc. since 2019.
Dr. Kramer's former positions include Head-Oncology Discovery Research at Janssen Pharmaceuticals, Inc. and Bristol-Myers Squibb Pharmaceuticals Ltd., and Assistant Professor at Harvard Medical School.
He received a doctorate degree from the University of Vermont.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
PORTAGE BIOTECH INC
0.74% | 31-03-2023 | 147 009 ( 0.74% ) | 82 766 $ | 31-03-2024 |
Actieve functies van Robert Kramer
Bedrijven | Functie | Begin |
---|---|---|
PORTAGE BIOTECH INC. | Chief Tech/Sci/R&D Officer | 08-01-2019 |
Phusis Therapeutics, Inc.
Phusis Therapeutics, Inc. BiotechnologyHealth Technology Phusis Therapeutics, Inc. is a private company that specializes in molecule therapeutics for cancer therapy. The company is based in Houston, TX and was founded by D. Lynn Kirkpatrick. The company focuses on developing inhibitors for PLEKHA7, RAL, Tiam1, and CERK, which are all important in cancer treatment. | Director/Board Member | 05-05-2014 |
iOX Therapeutics Ltd.
iOX Therapeutics Ltd. BiotechnologyHealth Technology iOX Therapeutics Ltd. provides cancer therapeutics services. The company was founded by Vincenzo Cerundolo in February 2015 and is headquartered in London, the United Kingdom. | Director/Board Member | 15-02-2022 |
Eerdere bekende functies van Robert Kramer
Bedrijven | Functie | Einde |
---|---|---|
Harvard Medical School | Corporate Officer/Principal | - |
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products are used for treatment of diseases like cancer, diabetes, arthritis, hepatitis, and psychiatric disorders. The company distributes products throughout the United Kingdom. Bristol-Myers Squibb Pharmaceuticals was founded in 1989 and is located in Uxbridge, UK. | Corporate Officer/Principal | - |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Corporate Officer/Principal | - |
SALVARX GROUP PLC | Founder | - |
Opleiding van Robert Kramer
University of Vermont | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
PORTAGE BIOTECH INC. | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products are used for treatment of diseases like cancer, diabetes, arthritis, hepatitis, and psychiatric disorders. The company distributes products throughout the United Kingdom. Bristol-Myers Squibb Pharmaceuticals was founded in 1989 and is located in Uxbridge, UK. | Health Technology |
Phusis Therapeutics, Inc.
Phusis Therapeutics, Inc. BiotechnologyHealth Technology Phusis Therapeutics, Inc. is a private company that specializes in molecule therapeutics for cancer therapy. The company is based in Houston, TX and was founded by D. Lynn Kirkpatrick. The company focuses on developing inhibitors for PLEKHA7, RAL, Tiam1, and CERK, which are all important in cancer treatment. | Health Technology |
iOX Therapeutics Ltd.
iOX Therapeutics Ltd. BiotechnologyHealth Technology iOX Therapeutics Ltd. provides cancer therapeutics services. The company was founded by Vincenzo Cerundolo in February 2015 and is headquartered in London, the United Kingdom. | Health Technology |
SalvaRx Group Plc
SalvaRx Group Plc BiotechnologyHealth Technology SalvaRx Group Plc engages in the development of drug that focuses on cancer immune-oncology. Its products portfolio includes iOx therapeutics, intensity therapeutics, nekonal oncology, and rift biotherapeutics. The company was founded by Ian B. Walters and Robert A. Kramer in 2007 and is headquartered in Ramsey, Isle of Man. | Health Technology |